FDA approvals on the horizon? no need for CR especially with 2.6mill R&D refund due this quarter. and not to mention increased sales. and perhaps sti and superbug detection kits get approvals soon on home soil. not to mention the small amount of shares on issue for retails purchase, the other 80+% held by top 20.... one of my favourite companies. not exactly sure how much top20 hold now. would be interesting to know.
Ann: Appendix 4C - quarterly, page-6
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
